Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

In children and adolescents with conduct disorder (CD), pharmacotherapy is considered when non-pharmacological interventions do not improve symptoms and functional impairment. Risperidone, a second-generation antipsychotic is increasingly prescribed off-label in this indication, but its efficacy and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Child Adolesc Psychiatry
Autors principals: Glennon, Jeffrey, Purper-Ouakil, Diane, Bakker, Mireille, Zuddas, Alessandro, Hoekstra, Pieter, Schulze, Ulrike, Castro-Fornieles, Josefina, Santosh, Paramala J., Arango, Celso, Kölch, Michael, Coghill, David, Flamarique, Itziar, Penzol, Maria J., Wan, Mandy, Murray, Macey, Wong, Ian C. K., Danckaerts, Marina, Bonnot, Olivier, Falissard, Bruno, Masi, Gabriele, Fegert, Jörg M., Vicari, Stefano, Carucci, Sara, Dittmann, Ralf W., Buitelaar, Jan K.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2013
Matèries:
Original Contribution
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4246122/
https://ncbi.nlm.nih.gov/pubmed/24337449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00787-013-0498-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars